← All organizations
Highest phase reached
Phase 4
First clinical trial
Dec 1, 2016Last known activity
May 6, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (19 distinct, 10 trials)
Phase 4 (6 own, 0 via acquisition)
Phase 3 (7 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Recent trials (12)
- NCT07051564Lead sponsorN/AMay 6, 2025
- NCT07051564OfficialN/AMay 6, 2025
- NCT06728839CollaboratorN/ADec 9, 2024
- NCT06683066CollaboratorPhase 1Dec 4, 2024
- NCT05802888CollaboratorPhase 4Mar 12, 2023
- NCT05431075CollaboratorPhase 4Jul 31, 2022
- NCT05802108Lead sponsorPhase 4Jul 1, 2022
- NCT05802108Reponsible party - principal investigatorPhase 4Jul 1, 2022
- NCT05432115CollaboratorPhase 4Jun 15, 2022
- NCT04400695Overall official - principal investigatorPhase 3Jul 31, 2020
- NCT03089957CollaboratorN/AApr 1, 2017
- NCT02985372CollaboratorPhase 3Dec 1, 2016
Details
- Last known activity
- May 6, 2025